A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 9 122,06 ₴, with a 24-hour trading volume of 15,29B ₴. The asset's market cap is 14,14T ₴, after moving 2.55% in the last day.
Tokenized AstraZeneca PLC is trading at 4 588,96 ₴, with a tokenized market cap of 34,41M ₴ and a 24-hour trading volume of 27,81M ₴. The tokenized asset has moved 3.12% in the past 24 hours.